The PICKUP Study

Complete Title: Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens (PICKUP)

PRINCIPAL INVESTIGATOR: JOSHUA HILL | PHASE: N/A

Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19

Complete title: A Phase 1 Study of DVX201, an Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19

PRINCIPAL INVESTIGATOR: JOSHUA HILL | PHASE: I

Study to Evaluate Viralym-M (ALVR105) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

Complete Title: Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Viralym-M Compared to Placebo for the Prevention of AdV, BKV, CMV, EBV, HHV-6, and JCV Infection and/or Disease, in High-Risk Patients After Allogeneic Hematopoietic Cell Transplant

PRINCIPAL INVESTIGATOR: JOSHUA HILL | PHASE: II

Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)

Complete Title: Phase 3 Multicenter, Double-Blind, Placebo-Controlled Trial of Viralym-M (ALVR105) for the Treatment of Patients With Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplant (HCT)

PRINCIPAL INVESTIGATOR: JOSHUA HILL | PHASE: III